A Study to Assess Plasma Ammonia Time-Normalized Area Under the Curve and Rate of Ureagenesis in Healthy Adult Subjects
Completed
Conditions studied: Ornithine Transcarbamylase Deficiency
In brief
The objective of the study is to characterize 24-hour plasma ammonia levels, characterize urea production rates in healthy normal subjects.
Key facts
- Study ID
- NCT04269122
- Run by
- Ultragenyx Pharmaceutical Inc
- People needed
- 120
- Starts
- 2019-08-02
- Expected to finish
- 2020-02-20
- Last updated by the study team
- 2020-03-30
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Body mass index between 18 and 30 kg/m2, inclusive.
You may not qualify if…
- History of liver disease as evidenced by any of the following: portal hypertension, ascites, splenomegaly, esophageal varices, hepatic encephalopathy, or a liver biopsy with evidence of stage 3 fibrosis.
- Significant hepatic inflammation or cirrhosis as evidenced by imaging or any of the following laboratory abnormalities: alanine aminotransferase (ALT) or aspartate aminotransferase (AST) greater than the upper limit of normal (ULN), total bilirubin >1.5 × ULN, alkaline phosphatase >2.5 × ULN. NOTE: the ALT and/or AST levels may be repeated.
- Subject has a history of gout.
- Plasma ammonia level that is not within normal limits at Screening in the opinion of the Investigator or Sponsor.
- Received any vaccine within 14 days prior to Screening.
- Pregnant, lactating, or intending to become pregnant at any time during the study.
- Blood transfusion within 8 weeks prior to Screening.diuretics, cyclophosphamide and other cytotoxic agents, tolbutamide, chlorpropamide, diazoxide, dichlorphenamide, pyrazinamide, probenecid, theophylline/aminophylline, riluzole, warfarin and other antithrombotic agents, supplements containing aluminum hydroxide, or iron supplements within 30 days of Part 1or Part 2.
Where it is running
- PPD Phase 1 Unit — Austin, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.